Bio-Techne (TECH) 10-K Summary — Year Ended Jun 30, 2023
Bio-Techne Corporation filed its annual report for the period ended June 30, 2023. The filing describes the company's business, risk factors, financial condition, and liquidity resources.
Key takeaway
Year ended Jun 30, 2023 · FY2025 10-K
Bio-Techne Corporation filed its annual report for the period ended June 30, 2023. The filing describes the company's business, risk factors, financial condition, and liquidity resources.
Financial snapshot
Selected annual figures reported with the filing, shown separately from the narrative summary.
Annual revenue
$1.1B
Revenue reported for the fiscal year.
Operating income
$298.9M
Income from operations reported for the year.
Net income
$285.3M
Net income reported for the year.
Operating cash flow
$254.4M
Cash generated by operating activities.
Annual revenue trend
Reported annual revenue and its change from the preceding fiscal year.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2021 | $931M | n/a |
| Jun 30, 2022 | $1.1B | +18.7% |
| Jun 30, 2023 | $1.1B | +2.8% |
Business overview
Bio-Techne Corporation operates in the life sciences and diagnostics sectors, providing tools and reagents for research and clinical applications. The company's business overview is outlined in Item 1 of the filing, covering its product portfolio and market focus.
Financial performance
Revenue increased from the prior period to the current period, while operating income and net income both showed positive results. Cash flow from operations was also reported as positive for the year.
Material risks
The filing identifies risk factors in Item 1A, including potential challenges related to business operations, market conditions, and regulatory changes. These risks are described without quantification or exaggeration.
Liquidity and capital
The company held cash, cash equivalents, and available-for-sale investments at the end of the period, with a portion located in the U.S. and the remainder in foreign jurisdictions. It also had significant unutilized availability under its revolving credit facility.
What to watch
Monitor changes in the company's cash and investment balances, as well as any shifts in the geographic distribution of those balances, in the next filing.